Top-News

Parnell Pharmaceuticals Holdings News

Keine aktuellen Kursdaten verfügbar
WKN: A14MJ5
ISIN: AU0000XINEU9
US-Symbol: PARNF
Typ: Aktie

Parnell Pharmaceuticals Holdings News

06.01.23 - PR Newswire
Parnell Pharmaceuticals Holdings Ltd Announces Extension of Rights Offering
Parnell Pharmaceuticals Holdings Ltd Announces Extension of Rights Offering PR Newswire
06.12.22 - PR Newswire
Parnell Pharmaceuticals Holdings Ltd Announces Commencement of Rights Offering
Parnell Pharmaceuticals Holdings Ltd Announces Commencement of Rights Offering PR Newswire
01.12.22 - PR Newswire
Parnell Pharmaceuticals Holdings Ltd Announces Proposed Rights Offering
Parnell Pharmaceuticals Holdings Ltd Announces Proposed Rights Offering PR Newswire
14.07.21 - ACCESSWIRE
Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum
SYDNEY, AUSTRALIA / ACCESSWIRE / July 14, 2021 / Parnell Pharmaceuticals Holdings Ltd (OTC PINK:PARNF), a fully integrated, commercial-​stage pharmaceutical company ...
29.01.21 - PR Newswire
DWHP Announces Expiration And Final Results Of Its Cash Tender Offer For All Outstanding Ordinary Shares Of Parnell Pharmaceuticals Holdings Ltd.
DWHP Announces Expiration And Final Results Of Its Cash Tender Offer For All Outstanding Ordinary Shares Of Parnell Pharmaceuticals Holdings Ltd. PR Newswire
22.01.21 - ACCESSWIRE
Notice of Annual General Meeting and Explanatory Memorandum
SYDNEY, AUSTRALIA / ACCESSWIRE / January 22, 2021 / Parnell Pharmaceuticals Holdings Ltd (OTC PINK:PARNF), a fully integrated, commercial-​stage pharmaceutical company ...
21.01.21 - PR Newswire
DWHP Announces Extension of The Expiration Time of Its Tender Offer
DWHP Announces Extension of The Expiration Time of Its Tender Offer PR Newswire
21.12.20 - PR Newswire
DW Healthcare Partners V, L.P. Announces Commencement of the Tender Offer for All Outstanding Ordinary Shares of Parnell Pharmaceuticals Holdings Ltd
DW Healthcare Partners V, L.P. Announces Commencement of the Tender Offer for All Outstanding Ordinary Shares of Parnell Pharmaceuticals Holdings Ltd PR Newswire
21.12.20 - ACCESSWIRE
Results of General Meeting of Shareholders Held December 17, 2020
SYDNEY, AUSTRALIA / ACCESSWIRE / December 21, 2020 / Parnell Pharmaceuticals Holdings Ltd (OTC PINK:PARNF), a fully integrated, commercial-​stage pharmaceutical ...
23.12.19 - ACCESSWIRE
Parnell Pharmaceuticals Holdings Ltd Announces Business Update
Parnell announces 2019 year-​to-date revenue growth of 9% over the first 9 months of 2018, start of work on its new 2019 CMO contract, and updates to 2019 financial results.
15.10.19 - ACCESSWIRE
Parnell Pharmaceuticals Holdings Ltd Announces New CDMO Agreement and Business Update
Parnell announces a new contract manufacturing agreement for one animal health product and a memorandum of understanding for two additional products with a global multi-...
07.06.19 - ACCESSWIRE
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Quarter Ended 31 March 2019
Parnell Delivers 9% Revenue Growth in Quarter 1 of 2019 Compared to 2018, and Confirms Provisional 2019 Guidance for a 17 - 25% Increase Over 2018 Revenue to $31 - $33 ...
30.04.19 - ACCESSWIRE
Notice of Annual General Meeting and Explanatory Memorandum
SYDNEY, AUSTRALIA / ACCESSWIRE / April 30, 2019 / Parnell Pharmaceuticals Holdings Ltd (OTC PINK: PARNF), a fully integrated, commercial-​stage pharmaceutical company ...
05.04.19 - ACCESSWIRE
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Year Ended 31 December 2018 and 2019 Guidance
Parnell Delivers 39% Revenue Growth and a $6.5 Million Improvement in EBITDA in 2018 Compared to 2017, Returns to NPAT Profitability, and Provides Provisional 2019 Guidance ...
02.11.18 - ACCESSWIRE
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Three Months Ended 30 September 2018
Parnell Delivers 39% Revenue Growth and a $5.9 Million Year-​to-Date Improvement in EBITDA as at the Third Quarter of 2018 Compared to the Same Period in 2017, Consolidates ...
15.12.17 - PR Newswire
Notice to Shareholders of Parnell Pharmaceuticals Holdings, Ltd regarding Extraordinary General Meeting
Notice to Shareholders of Parnell Pharmaceuticals Holdings, Ltd regarding Extraordinary General Meeting PR Newswire
24.07.14 - PR Newswire
Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration
Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration Company inks deal with CIMTECH Pty Ltd to develop new ...

Newssuche

Videos

newspaper
25.04.24 +21,95%
Technical Trading: S&P 500 Short Chance
S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »